GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Granules India Ltd (NSE:GRANULES) » Definitions » Price-to-Owner-Earnings

Granules India (NSE:GRANULES) Price-to-Owner-Earnings : 45.98 (As of May. 23, 2024)


View and export this data going back to 2005. Start your Free Trial

What is Granules India Price-to-Owner-Earnings?

As of today (2024-05-23), Granules India's share price is ₹429.45. Granules India's Owner Earnings per Share (TTM) ended in Mar. 2024 was ₹9.34. It's Price-to-Owner-Earnings for today is 45.98.


The historical rank and industry rank for Granules India's Price-to-Owner-Earnings or its related term are showing as below:

NSE:GRANULES' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 6.68   Med: 44.59   Max: 3918.57
Current: 43.01

During the past 13 years, the highest Price-to-Owner-Earnings of Granules India was 3918.57. The lowest was 6.68. And the median was 44.59.


NSE:GRANULES's Price-to-Owner-Earnings is ranked worse than
70% of 420 companies
in the Drug Manufacturers industry
Industry Median: 27.395 vs NSE:GRANULES: 43.01

As of today (2024-05-23), Granules India's share price is ₹429.45. Granules India's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ₹16.72. Therefore, Granules India's PE Ratio for today is 25.68.

As of today (2024-05-23), Granules India's share price is ₹429.45. Granules India's EPS without NRI for the trailing twelve months (TTM) ended in was ₹16.72. Therefore, Granules India's PE Ratio without NRI for today is 25.68.

During the past 13 years, Granules India's highest PE Ratio without NRI was 31.36. The lowest was 6.15. And the median was 17.42.


Granules India Price-to-Owner-Earnings Historical Data

The historical data trend for Granules India's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Granules India Price-to-Owner-Earnings Chart

Granules India Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.43 31.91 50.75 12.52 46.01

Granules India Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.52 - - - 46.01

Competitive Comparison of Granules India's Price-to-Owner-Earnings

For the Drug Manufacturers - Specialty & Generic subindustry, Granules India's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Granules India's Price-to-Owner-Earnings Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Granules India's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Granules India's Price-to-Owner-Earnings falls into.



Granules India Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Granules India's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=429.45/9.34
=45.98

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Granules India  (NSE:GRANULES) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Granules India Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Granules India's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Granules India (NSE:GRANULES) Business Description

Traded in Other Exchanges
Address
3rd Block, My Home Hub, 2nd Floor, Madhapur, Hyderabad, TG, IND, 500 081
Granules India Ltd is an India-based pharmaceutical company. The company manufactures active pharmaceutical ingredients, pharmaceutical formulation intermediates and finished dosages. Its business is organized into three areas; the Core business which comprises core molecules such as Paracetamol, Ibuprofen, Metformin, Guaifenesin, and Methocarbamol; the Emerging business that focuses on manufacturing APIs and the US Generics. It has one segment Pharmaceutical products including ingredients and intermediaries. Its primary geographic markets are North America, Latin America, Europe, India, and Rest of World.

Granules India (NSE:GRANULES) Headlines

No Headlines